What Happened?
Cambridge, MA-based Affinivax Appointed Vanya Sagar as Chief People Officer
About the Company
Affinivax is a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines designed to induce a broad and robust protective immune response to both disease-relevant polysaccharides and disease-relevant proteins in a single vaccine. Affinivax designs each of its vaccine candidates to optimize the protective immune response to one or both of these antigens utilizing the distinctive plug-and-play nature of its proprietary MAPS™ technology platform, presenting the potential opportunity to make a significant step forward in addressing major healthcare challenges posed by novel and resistant infectious diseases. Affinivax was founded in 2014 with a seed investment from the Bill & Melinda Gates Foundation and an exclusive license to the MAPS technology from Boston Children`s Hospital.
About the Person
Vanya Sagar is Chief People Officer at Sionna Therapeutics. Previously, Vanya held various senior HR leadership roles in the industry.
Info Source
News
Short Profile